Impact of high-risk features on disease-free survival (DFS) in patients (pts) with high-risk stage II colon cancer (CC) in ACHIEVE-2 trial as part of the IDEA collaboration.

被引：0

作者：

Manaka, Dai

Shiozawa, Manabu

Kotaka, Masahito

Gamoh, Makio

Shiomi, Akio

Makiyama, Akitaka

Munemoto, Yoshinori

Rikiyama, Toshiki

Fukunaga, Mutsumi

Ueki, Takashi

Shitara, Kohei

Shinkai, Hiroshi

Tanida, Nobuyuki

Oki, Eiji

Yamazaki, Kentaro

Sunami, Eiji

Yamanaka, Takeharu

Yoshino, Takayuki

Ohtsu, Atsushi

Maehara, Yoshihiko

机构：

[1] Kyoto Katsura Hosp, Kyoto, Japan

[2] Kanagawa Canc Ctr, Dept Gastrointestinal Surg, Yokohama, Kanagawa, Japan

[3] Sano Hosp, Gastrointestinal Canc Ctr, Kobe, Hyogo, Japan

[4] Osaki Citizen Hosp, Dept Med Oncol, Osaki, Japan

[5] Shizuoka Canc Ctr Hosp, Div Colon & Rectal Surg, Shizuoka, Japan

[6] Japan Community Hlth Care Org, Kyushu Hosp, Dept Hematol Oncol, Kitakyushu, Fukuoka, Japan

[7] Fukui Ken Saiseikai Hosp, Fukui, Japan

[8] Jichi Med Univ, Saitama, Japan

[9] Hyogo Prefectural Nishinomiya Hosp, Nishinomiya, Hyogo, Japan

[10] Hamanomachi Hosp, Dept Surg, Fukuoka, Japan

[11] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan

[12] Chigasaki Municipal Hosp, Dept Surg, Chigasaki, Kanagawa, Japan

[13] Japanese Red Cross Kochi Hosp, Dept Surg, Kochi, Japan

[14] Kyushu Univ, Fukuoka, Japan

[15] Shizuoka Canc Ctr, Div Gastrointestinal Oncol, Shizuoka, Japan

[16] Japanese Red Cross Med Ctr, Dept Surg Oncol, Tokyo, Japan

[17] Yokohama City Univ, Sch Med, Dept Biostat, Yokohama, Kanagawa, Japan

[18] Kyushu Cent Hosp, Fukuoka, Japan

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

4011

引用

页数：2

共 50 条

[31] PROLONG TEGAFUR/URACIL AND LEUCOVORIN ADJUVANT CHEMOTHERAPY IMPROVING DISEASE-FREE AND OVERALL SURVIVAL IN HIGH-RISK STAGE II COLORECTAL CANCER.
Yu, Y.
DISEASES OF THE COLON & RECTUM, 2016, 59 (05) : E232 - E232
[32] Outcomes of adjuvant chemotherapy (AC) in young (YP) and elderly patients (EP) with high-risk stage II colon cancer (CC)
Kumar, Aalok
Kennecke, Hagen F.
Lim, Howard John
Renouf, Daniel John
Gill, Sharlene
Woods, Ryan
Speers, Caroline
Cheung, Winson Y.
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
[33] Adjuvant chemotherapy (AC) outcomes in young (YP) and elderly patients (EP) with high-risk stage II colon cancer (CC)
Kumar, Aalok
Kennecke, Hagen F.
Lim, Howard John
Renouf, Daniel John
Gill, Sharlene
Woods, Ryan
Speers, Caroline
Cheung, Winson Y.
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
[34] Postoperative chemotherapy use and survival in non-high-risk young and high-risk old-aged patients with stage II colon cancer
Tian Jin
Yingshuang Zhu
Wei Lu
Chenqin Le
Lijuan Wang
Qian Xiao
Kefeng Ding
Holistic Integrative Oncology, 2 (1):
[35] Adjuvant chemotherapy improves survival in high-risk stage II colon cancer: a retrospective cohort study
Liu, Lin-Lin
Xiang, Zuo-Lin
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2022, 15
[36] Adjuvant Chemotherapy in High-risk Stage II Colon Cancer Patients: (Un) common Practice?
Koebrugge, B.
Van Steenbergen, L. N.
Lips, D. J.
Lemmens, V. E.
Van der Linden, H. C.
Pruijt, H. F.
Liefers, G.
Van de Velde, C. J.
Bosscha, K.
ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : S103 - S103
[37] Clinical Implications of Mismatch Repair Status in Patients With High-risk Stage II Colon Cancer
Baek, Dong Won
Kang, Byung Woog
Lee, Soo Jung
Kim, Hye Jin
Park, Su Yeon
Park, Jun Seok
Choi, Gyu Seog
Baek, Jin Ho
Kim, Jong Gwang
IN VIVO, 2019, 33 (02): : 649 - 657
[38] Impact of Hormone Receptor Status and Ki-67 Expression on Disease-Free Survival in Patients Affected by High-risk Endometrial Cancer
Di Donato, Violante
Iacobelli, Valentina
Schiavi, Michele Carlo
Colagiovanni, Vanessa
Pecorella, Irene
Palaia, Innocenza
Perniola, Giorgia
Marchetti, Claudia
Musella, Angela
Tomao, Federica
Monti, Marco
Muzii, Ludovico
Panici, Pierluigi Benedetti
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 (03) : 505 - 513
[39] Adjuvant chemotherapy is not associated with improved survival for all high-risk factors in stage II colon cancer
Verhoeff, S. R.
van Erning, F. N.
Lemmens, V. E. P. P.
de Wilt, J. H. W.
Pruijt, J. F. M.
INTERNATIONAL JOURNAL OF CANCER, 2016, 139 (01) : 187 - 193
[40] The Impact of Lymphovascular Invasion on Recurrence-Free Survival in Patients with High-Risk Stage II Colorectal Cancer Treated with Adjuvant Therapy
Bozkurt, Oktay
Firat, Sedat Tarik
Dogan, Ender
Inanc, Mevlude
Deniz, Kemal
Zararsiz, Gozde Erturk
Ozkan, Metin
ERCIYES MEDICAL JOURNAL, 2019, 41 (02) : 191 - 195

← 1 2 3 4 5 →